Sumitomo Mitsui Trust Holdings, Inc. Repare Therapeutics Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 277,168 shares of RPTX stock, worth $970,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
277,168
Previous 308,449
10.14%
Holding current value
$970,088
Previous $1.45 Million
37.05%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RPTX
# of Institutions
69Shares Held
36.8MCall Options Held
51.7KPut Options Held
17.7K-
Bvf Inc San Francisco, CA10.3MShares$36.2 Million1.04% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$11.8 Million4.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$11.6 Million0.26% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$10.4 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$9.26 Million19.39% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $147M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...